Frazier Life Sciences Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-203,684
| Closed | -$5.6M | – | 54 |
|
|
2024
Q1 | $5.6M | Hold |
203,684
| – | – | 0.24% | 44 |
|
|
2023
Q4 | $6.21M | Hold |
203,684
| – | – | 0.33% | 44 |
|
|
2023
Q3 | $6.44M | Hold |
203,684
| – | – | 0.43% | 39 |
|
|
2023
Q2 | $8.31M | Hold |
203,684
| – | – | 0.5% | 36 |
|
|
2023
Q1 | $7.59M | Hold |
203,684
| – | – | 0.55% | 36 |
|
|
2022
Q4 | $7.11M | Hold |
203,684
| – | – | 0.44% | 36 |
|
|
2022
Q3 | $11.4M | Hold |
203,684
| – | – | 0.88% | 27 |
|
|
2022
Q2 | $10.5M | Hold |
203,684
| – | – | 1% | 27 |
|
|
2022
Q1 | $14.8M | Buy |
+203,684
| New | +$14.8M | 1.26% | 28 |
|